Citizens Downgrades Cellectis to Market Perform

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

Citizens analyst Silvan Turkcan downgrades Cellectis (NASDAQ:CLLS) from Market Outperform to Market Perform.

Comments

No comments yet. Be the first!